Evidence map›Paper›PMID 26252890›Full record

ArticlePloS one2015

Evaluation of the BDCA2-DTR Transgenic Mouse Model in Chronic and Acute Inflammation.

Manuela Mandl, Maik Drechsler, Yvonne Jansen, Carlos Neideck, Heidi Noels, Alexander Faussner, Oliver Soehnlein, Christian Weber, Yvonne Döring

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Immunobiology of Atherosclerosis: A Complex Net of Interactions.International journal of molecular sciences · 2019
    Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Manuela MandlInstitute for Cardiovascular Prevention, Ludwig-Maximilians-University Munich, Munich, Germany.
Maik DrechslerInstitute for Cardiovascular Prevention, Ludwig-Maximilians-University Munich, Munich, Germany; Academic Medical Center, Department of Pathology, Amsterdam University, Amsterdam, the Netherlands; DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany.
Yvonne JansenInstitute for Cardiovascular Prevention, Ludwig-Maximilians-University Munich, Munich, Germany.
Carlos NeideckInstitute for Cardiovascular Prevention, Ludwig-Maximilians-University Munich, Munich, Germany.
Heidi NoelsInstitute for Molecular Cardiovascular Research, RWTH Aachen University Aachen, Aachen, Germany.
Alexander FaussnerInstitute for Cardiovascular Prevention, Ludwig-Maximilians-University Munich, Munich, Germany.
Oliver SoehnleinInstitute for Cardiovascular Prevention, Ludwig-Maximilians-University Munich, Munich, Germany; Academic Medical Center, Department of Pathology, Amsterdam University, Amsterdam, the Netherlands; DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany.
Christian WeberInstitute for Cardiovascular Prevention, Ludwig-Maximilians-University Munich, Munich, Germany; DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany.
Yvonne DöringInstitute for Cardiovascular Prevention, Ludwig-Maximilians-University Munich, Munich, Germany; DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany.
Ludwig-Maximilians-Universität München · DEGerman Centre for Cardiovascular Research · DERWTH Aachen University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimsPlasmacytoid dendritic cells (pDCs) are a small subset of dendritic cells and the main producers of type I interferons. Besides their contribution to tolerance, they are known to be involved in autoimmune diseases and have recently been implicated in atherosclerosis. However, their precise involvement, particularly in advanced lesion development, remains elusive. Hence, we investigated the role of pDCs in atherogenesis vs atheroprogression by specifically depleting this cell population using the BDCA2-DTR mouse model bred to Apolipoprotein E (Apoe-/-) deficient mice. METHODS AND

resultsOur results revealed that continuous diphtheria toxin-induced pDC depletion in Apoe-/- BDCA2-DTR mice receiving a high-fat diet (HFD) for 4 weeks did not alter lesion size or composition. Instead, these mice displayed increased B cell numbers and altered levels of inflammatory cytokines. Analysis of depletion efficiency showed that complete pDC depletion could only be sustained for one week and reoccurring pDCs sorted after 4 weeks did not express DTR anymore. Consequently, we analyzed lesion development in a model of partial carotid ligation, inducing established lesions after 5 weeks of HFD feeding, and only depleted pDCs during the last week of 5 weeks HFD feeding. Despite short-term, but efficient pDC depletion, we observed no differences in atherosclerotic lesion development, but changes in inflammatory cytokine titers. To assure the functionality of the BDCA2-DTR model in acute settings, we additionally examined the effect of pDC depletion in an indirect acute lung injury (iALI) model. This time, efficient pDC depletion resulted in a significantly reduced macrophage and neutrophil accumulation in the lung 12 hours after LPS challenge, underlining a pro-inflammatory role of pDCs in the innate immune response in iALI.

conclusionTaken together, the BDCA2-DTR mouse model only allows efficient pDC depletion for one week, which subsequently restricts its usability to more acute but not chronic inflammatory disease models.

Indexed as

Acute DiseaseAcute Lung InjuryAnimalsApolipoproteins EAtherosclerosisBone MarrowCell CountChronic DiseaseDendritic CellsDiet, High-FatDiphtheria ToxinDisease Models, AnimalInflammationLeukocyte Common AntigensLipidsLipopolysaccharidesApolipoproteins EDiphtheria ToxinLeukocyte Common AntigensLipidsLipopolysaccharides

Identifiers

PMID26252890
PMCPMC4529211
OpenAlexW2169475162

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.